Combining Epidemiology & Economics for Measurement of Cancer Costs Workshop Agenda
Combining Epidemiology & Economics for Measurement of Cancer Costs
Villa Mondragone, Italy
September 21 - 24, 2010
Presentations
Copies of the presentation files from this workshop are available by e-mail;
please make your request to Susan Scott at scotts2@mail.nih.gov.
If you have difficulty viewing the files, please contact the ARP Web staff.
Tuesday, September 21 evening (Tenuta di Pietra Porzia)
6:00pm |
Arrival and Opening
Welcome to the participants
Introduction of the Workshop: Goals, Program
Dinner |
Wednesday, September 22 (Villa Mondragone)
8:30am – 9:00am |
Registration |
9:15am – 10:00am |
Introduction of participants |
Session I: Prevalence and survival estimation
Moderator: Timo Hakulinen (Finland)
Organizer:Anna Gigli (Italy)
10:00am – 11:00am |
Long term survival, estimation of the proportion cured
Paul Lambert (UK)
Updating survival figures, cohort vs. period approach
Hermann Brenner (Germany)
Prevalence by time since diagnosis, complete prevalence and phases of care and recurrences, extrapolation of prevalence into the future
Angela Mariotto (USA) |
11:00am – 11:30am |
Discussion |
11:30am – 12:00noon |
Break |
Session 2: Methods to calculate medical care cost
Moderator: Mark Hornbrook (USA)
Organizer:Robin Yabroff (USA)
12:00noon – 1:00pm |
What is meant by cancer costs? What is to be included?
Joseph Lipscomb (USA)
Use of administrative data to develop longitudinal costing models
Murray Krahn (Canada) |
1:00pm – 2:30pm |
Lunch |
2:30pm – 3:30pm |
Methods to calculate medical costs in Europe: mission impossible?
Andrea Manca (UK)
Do we take into account other costs such as lost productivity, patients’ time? Methods to
calculate other costs
Jeffrey Hoch (Canada) |
3:30pm – 4:00pm |
Break |
4:00pm – 4:30pm |
The Italian case study
Silvia Francisci (Italy), Anna Gigli (Italy), Maura Mezzetti (Italy), Francesco Giusti (Italy), Stefano Guzzinati (Italy) |
4:30pm – 5:00pm |
Discussion |
Thursday, September 23 (Villa Mondragone)
Session 3: Cost-effectiveness, cost-benefit and decision modeling
Moderator: Eric Feuer (USA)
Organizer:Maura Mezzetti (Italy)
9:30am – 10:30am |
Modelling drivers of cost and benefit for policy development in cancer
Ruth Etzioni (USA)
Economic evaluation of cancer screening - case of colorectal cancer
Iris Lansdorp-Vogelaar (The Netherlands) |
10:30am – 11:00am |
Break |
11:00am – 12:00noon |
Using whole disease models to support the economic analysis of cancer interventions
Paul Tappenden (UK)
Economic evaluation of cancer specific targeted therapies
Isabelle Durant-Zalesky (France) |
12:00noon – 12:30pm |
Discussion |
12:30pm – 2:00pm |
Lunch |
Session 4: Forecasting, uncertainty
Moderator: Ruth Etzioni (USA)
Organizer:Silvia Francisci (Italy)
2:00pm – 3:00pm |
Modifiable health behaviors and methods for analyzing changes in costs over time
Paul Fishman (USA), Mark Hornbrook (USA)
Model uncertainty in cost-effectiveness analysis
Christian Asseburg (Finland) |
3:00pm – 3:30pm |
Break |
3:30pm – 4:00pm |
Projections of cancer incidence and survival and corresponding costs
Robin Yabroff (USA) |
4:00pm – 4:30pm |
Discussion |
Friday, September 24 (Villa Mondragone)
Session 5: Round table: discussion topics
Moderator: Joseph Lipscomb (USA)
Organizer:Franco Berrino (Italy)
9:30am – 11:00am |
Data Issues: linkage of cancer registry data and administrative data – Challenges
Comparisons: US vs. Canada; fee-for-service vs. managed care |
11:00am – 11:30am |
Break |
11:30am – 1:00pm |
Country-specific experiences
Next steps: publication, networking for EU projects
Closing Remarks |
|